Flow cytometry, ELISPOT analysis of PBMCIncreased frequency of total IL-17+ cells and of CD4+IL-17+ cells 12 weeks after initiation of therapy in RA and AS patients. The gene discussed is CD4; the disease is rheumatoid arthritis.